Recommendations for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease in China
10.3760/cma.j.cn112138-20220525-00406
- VernacularTitle:结缔组织病相关间质性肺疾病诊疗规范
- Author:
Qinghua ZOU
1
;
Yuewu LU
;
Jingguo ZHOU
;
Xiaoxia LIU
;
Mengtao LI
;
Yan ZHAO
Author Information
1. 陆军军医大学第一附属医院风湿免疫科, 重庆400038
- Keywords:
Connective tissue diseases;
Lung diseases,interstitial Diagnosis;
Treatment;
Prognosis
- From:
Chinese Journal of Internal Medicine
2022;61(11):1217-1223
- CountryChina
- Language:Chinese
-
Abstract:
Interstitial lung disease (ILD) is a frequent complication of patients with connective tissue disease (CTD) and significantly affects morbidity and mortality. Disease course may vary from stable or mildly progressive to more severe, with rapid loss of lung function. At present, there are great challenges and poor prognosis in the diagnosis and treatment of CTD-ILD. Based on the evidence and guidelines from China and other countries, experts from the Chinese Rheumatology Association developed standardization of diagnosis and treatment of CTD-ILD. The aim is to strengthen the early identification of, standardize the diagnosis and treatment of CTD-ILD, and delay the progress of the disease.
